ATE87007T1 - Fusionsprotein, enthaltend lymphotoxin. - Google Patents

Fusionsprotein, enthaltend lymphotoxin.

Info

Publication number
ATE87007T1
ATE87007T1 AT88904653T AT88904653T ATE87007T1 AT E87007 T1 ATE87007 T1 AT E87007T1 AT 88904653 T AT88904653 T AT 88904653T AT 88904653 T AT88904653 T AT 88904653T AT E87007 T1 ATE87007 T1 AT E87007T1
Authority
AT
Austria
Prior art keywords
protein
fusion protein
protein containing
lymphotoxin
ppralt
Prior art date
Application number
AT88904653T
Other languages
English (en)
Inventor
Tetsuzo Miki
Seishi Kato
Hiroshi Osada
Original Assignee
Sagami Chem Res
Central Glass Co Ltd
Hodogaya Chemical Co Ltd
Nissan Chemical Ind Ltd
Tosoh Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chem Res, Central Glass Co Ltd, Hodogaya Chemical Co Ltd, Nissan Chemical Ind Ltd, Tosoh Corp filed Critical Sagami Chem Res
Application granted granted Critical
Publication of ATE87007T1 publication Critical patent/ATE87007T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT88904653T 1987-05-29 1988-05-28 Fusionsprotein, enthaltend lymphotoxin. ATE87007T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13172687 1987-05-29
PCT/JP1988/000525 WO1988009343A1 (fr) 1987-05-29 1988-05-28 Proteine fusionnee contenant une lymphotoxine
EP88904653A EP0317641B1 (de) 1987-05-29 1988-05-28 Fusionsprotein, enthaltend lymphotoxin

Publications (1)

Publication Number Publication Date
ATE87007T1 true ATE87007T1 (de) 1993-04-15

Family

ID=15064759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904653T ATE87007T1 (de) 1987-05-29 1988-05-28 Fusionsprotein, enthaltend lymphotoxin.

Country Status (6)

Country Link
US (1) US5095096A (de)
EP (1) EP0317641B1 (de)
JP (1) JPH082315B2 (de)
AT (1) ATE87007T1 (de)
DE (1) DE3879395T2 (de)
WO (1) WO1988009343A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004692A (en) * 1987-12-15 1991-04-02 Protein Design Labs, Inc. Cloning and expression of phosopholipase C genes
IE63847B1 (en) * 1989-05-05 1995-06-14 Res Dev Foundation A novel antibody delivery system for biological response modifiers
US6267964B1 (en) 1989-08-01 2001-07-31 Affibody Technology Sweden Ab Stabilized protein or peptide conjugates able to bond albumin having extended biological half-lives
SE509359C2 (sv) * 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US5314995A (en) * 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
US5238823A (en) * 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
US5594107A (en) * 1990-08-22 1997-01-14 University Of Saskatchewan Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
US5273889A (en) * 1990-08-22 1993-12-28 University Of Saskatchewan Gamma-iterferon-leukotoxin gene fusions and uses thereof
DE69129697T3 (de) * 1990-08-29 2004-01-29 Inst Genetics Llc Aus mehreren domänen bestehende hämatopoese-stimulatoren
JPH05255393A (ja) * 1990-09-21 1993-10-05 Ishihara Sangyo Kaisha Ltd ポリペプチド
US5525491A (en) * 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
EP0965597A4 (de) * 1996-12-27 2003-01-08 Mochida Pharm Co Ltd Zellmembran-wirksame medikamente
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
EP1414471B1 (de) 2001-07-17 2012-06-13 Research Development Foundation Therapeutische Mittel mit pro-apoptotischen Proteinen
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7495090B2 (en) 2002-05-23 2009-02-24 The Regents Of The University Of California Nucleic acids encoding chimeric CD154 polypeptides
US9493543B2 (en) 2010-02-16 2016-11-15 Novo Nordisk A/S Factor VIII fusion protein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
SE462046C (sv) * 1982-08-23 1998-04-27 Pharmacia Biotech Ab Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
NZ212312A (en) * 1984-06-07 1988-09-29 John Richard Murphy Hybrid protein comprising fragments of diphtheria toxin and part of cell-specific ligand; and fused gene therefor
EP0196864A3 (de) * 1985-03-25 1988-03-23 Cetus Corporation Behandlung und Sekretion von rekombinanten Proteinen mittels alkalischer Phosphatase, dazu verwendbare DNA-Sequenzen und mittels dieser Sequenzen transformierte Zellen
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering

Also Published As

Publication number Publication date
JPH082315B2 (ja) 1996-01-17
EP0317641B1 (de) 1993-03-17
US5095096A (en) 1992-03-10
EP0317641A4 (en) 1991-07-24
EP0317641A1 (de) 1989-05-31
JPH082315B1 (de) 1996-01-17
DE3879395D1 (de) 1993-04-22
WO1988009343A1 (fr) 1988-12-01
DE3879395T2 (de) 1993-06-24

Similar Documents

Publication Publication Date Title
DE3879395D1 (de) Fusionsprotein, enthaltend lymphotoxin.
NO863806D0 (no) Arab promotorer og fremgangsmaate for fremstilling av polypeptider inkludert cecropiner, ved mikrobiologiske teknikker.
DE68926882D1 (de) Plasmidvektor mit pectatlyase-signalsequenz
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
ES8605040A1 (es) Procedimiento para preparar un polipeptido con actividad de hirudina
FI943563A0 (fi) Uusia biologisesti aktiivisia polypeptidejä, niiden valmistus ja niitä sisältävä farmaseuttinen koostumus
ATE302275T1 (de) Hämatopoietisches fusionsprotein multivariantes il-3 enthaltend
DK422288A (da) Dna-konstruktioner indeholdende en kluyveromyces-alfa-faktor-ledersekvens til at dirigere sekretion af heterologe polypeptider
NO176481C (no) Fremgangsmåte for fremstilling av et fusjonsprotein
RU93045577A (ru) Слитные полипептиды
NZ222856A (en) Equine interferon gamma (eq ifn alpha), dna sequences for its recombinant production and monoclonal antibodies thereto
KR900701819A (ko) 박테리아에서 폴리펩티드 번역 후 수식을 유도하는 선도 서열 및 그의 유전자
DK192189D0 (da) Polypeptid, fremgangsmaade til inhibering af fibrinogen, fremgangsmaade til rensning af et polypeptid, gen indeholdende rekombinante dna kodende for et polypeptid, vektor, cellekultur og fremgangsmaade til fremstilling af et cysteinrigt polypeptid
ATE170556T1 (de) Dna-sequenzen, vektoren und fusionspolypeptide zur erhöhung der sekretion gewünschter polypeptide von filamentösen fungi
ATE154638T1 (de) Mutanten von interleukin-3
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
SE8101004L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos humant interferon, dna och plasmider, som koderar for denna sekvens, mikroorganismer, som innehaller dessa genetiska informationer och forfarande
ATE92961T1 (de) Dns-sequenz.
DE3585406D1 (de) Expressionskontrollsequenzen.
NO883611D0 (no) Ekspresjonsplasmider inneholdende deo promoter og bakterielle verter inneholdende plasmider.
JPS6460388A (en) Gene coding linked material of protein a-like substance fc bond region, recombinant plasmid containing said gene and transformant produced by using said recombinant plasmid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties